あくせいえいようしっちょうの英語

本発明はまた、喘息、アレルギー性喘息、非アレルギー性（内因性）喘息、アレルギー性鼻炎、アトピー性皮膚炎、アレルギー性結膜炎、湿疹、じんま疹、食物アレルギー、慢性閉塞性肺疾患、潰瘍性大腸炎、ＲＳＶ感染、ブドウ膜炎、強皮症、または骨粗鬆症を含むアレルギー性疾患のような、ＩＬ１３媒介疾患の処置におけるこれら抗体の使用に関する。例文帳に追加

The invention also relates to the use of these antibodies in the treatment of IL13-mediated diseases, such as allergic disease, including asthma, allergic asthma, non-allergic (intrinsic) asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, eczema, urticaria, food allergies, chronic obstructive pulmonary disease, ulcerative colitis, RSV infection, uveitis, scleroderma, and osteoporosis. - 特許庁

本発明はまた、喘息、アレルギー性喘息、非アレルギー性（内因性）喘息、アレルギー性鼻炎、アトピー性皮膚炎、アレルギー性結膜炎、湿疹、じんま疹、食物アレルギー、慢性閉塞性肺疾患、潰瘍性大腸炎、ＲＳＶ感染、ブドウ膜炎、強皮症、または骨粗鬆症を含むアレルギー性疾患のような、ＩＬ１３媒介疾患の処置におけるこれら抗体の使用に関する。例文帳に追加

The use of these antibodies in the treatment of IL13-mediated diseases, such as asthma, allergic asthma, non-allergic (intrinsic) asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, eczema, urticaria, food allergies, chronic obstructive pulmonary disease, ulcerative colitis, RSV infection, uveitis, scleroderma, and allergic diseases including osteoporosis, is also provided. - 特許庁

過反応性炎症性疾患および自己免疫疾患に対する治療および／または予防のための薬剤、特に全身性エリテマトーデス様病巣の発達抑制のための薬剤を調製するためのデオキシスパガリン（ＤＳＧ）の使用であって、前記治療はサイクルにおいて実施される、使用。例文帳に追加

Use of deoxysupergualin (DSG) for the preparation of a pharmaceutical for the treatment and/or prevention of hyperreactive inflammatory diseases and the autoimmune diseases, particularly for the growth inhibition of systemic lupus erythematosus-like focus is provided, and the treatment is carried out in a cycle. - 特許庁

免疫機能の異常亢進を伴う疾患の治療薬または予防薬として有用なＩＬ−５の産生を選択的に抑制することを特徴とするサイトカイン産生抑制剤を提供する。例文帳に追加

To provide a cytokine production depressant useful as a medicine for curing or preventing a disease with abnormal sthenia of immune function, that is characterized by selectively controlling IL-5 production. - 特許庁

乳由来塩基性タンパク質画分を有効成分としたRANKL産生抑制剤、このRANKL産生抑制剤を配合した骨代謝疾患用治療剤ならびに免疫疾患用治療剤、さらには、このRANKL産生抑制剤を特定量配合した、RANKL産生抑制を特徴とする飲食品ならびに飼料はRANKLの産生を抑制する効果が顕著である。例文帳に追加

The RANKL production inhibitor using the milk-derived basic protein fraction as an active ingredient, the bone metabolic disease-treating agent and immune disease-treating agent by blending the RANKL production inhibitor and also the foods, beverages and feeds characterized by the RANKL production inhibitory activity, blended with the RANKL production inhibitor by a specific amount have marked effects of inhibiting the RANKL production. - 特許庁

日記の家では歴代の当主が単に日記を執筆したり所持するだけでなく、家記から写本や抄本、部類記の作成や内容の研究を通じてそこに書かれた有職故実の内容を吸収するとともに、家記の喪失を防いで朝廷の官吏あるいは摂関家の家司・家礼として奉仕できる体制を整えることで家名の安定を図っていった。例文帳に追加

In such "houses with diaries," beyond simply having the family head of each successive generation record and then maintain ownership of a diary, family members would also make manuscript copies, abridged versions, and indices (by topic or category) of the house diary, and gain a thorough understanding and knowledge of court practices through research into what was recorded therein; moreover, such families also tried to guard against the possibility of losing their house diaries by setting up a governmental system in which they themselves could serve the Imperial Court as officials or the Sekkanke (the line of regents and advisors) as keishi (clerks and household superintendents) and karei (house retainers), thereby aiming to keep their family name stable and secure.発音を聞く  - Wikipedia日英京都関連文書対訳コーパス

さらに、開示されているのは、呼吸性、炎症性もしくは閉塞性の気道疾患の予防もしくは処置における同時投与もしくは逐次投与のための、抗コリン作用薬およびコルチコステロイド；抗コリン作用薬および長時間作用性βアゴニスト；もしくはコルチコステロイドおよび長時間作用性βアゴニストの組み合わせを基にした、吸入可能な薬物および方法である。例文帳に追加

There are provided inhalable medicaments and methods based on combinations of: an anticholinergic and a corticosteroid; an anticholinergic and a long acting β agonist; or a corticosteroid and a long acting β agonist, for simultaneous or sequential administration in the prevention or treatment of the respiratory, inflammatory or obstructive airway disease. - 特許庁

下記の一般式Ｉで示される新規アミノベンゾフェノン誘導体は、インターロイキン１β（ＩＬ−１β）および腫瘍壊死因子α（ＴＮＦ−α）の分泌をインビトロで強力に抑制し、それ故、サイトカイン、またはとりわけインターロイキン１β（ＩＬ−１β）および腫瘍壊死因子α（ＴＮＦ−α）の分泌および調節が発病に関与する炎症性疾患の処置に有効である。例文帳に追加

The new aminobenzophenone derivative is represented by general formula (I), strongly suppresses the secretion of interleukin 1β (IL-1β) and a tumor necrosis factor α (TNF-α) in vitro, and therefore is effective for treating inflammatory disease of which the disease development engages with the secretion and regulation of cytokine or especially interleukin 1β (IL-1β) and a tumor necrosis factor α (TNF-α). - 特許庁